Local therapy in HCC brain metastases was linked to longer survival versus supportive care alone. Find out more about the ...
Rznomics a biopharmaceutical company specializing in RNA-based gene therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy ...
Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced the publication of a study in the Journal of Hepatology demonstrating the performance of HelioLiver™, ...
Josep M. Llovet, MD, Senior Investigator, Barcelona-Clínic Liver Cancer (BCLC) Group; Liver Unit, Digestive Disease Institut; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS); ...
Researchers at National Taiwan University have developed a liver-directed IL-10 gene therapy that strengthens cancer-fighting ...
Introduction Risk Factors and High-Risk Populations Screening Tools Screening Recommendations References A cost-effectiveness model shows a ≥ 3-month gain in life expectancy at a cost of < $50,000 per ...
Disparities in liver cancer risk and outcomes in the LGBTQ community: A literature review. Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A ...
Clinicians in 5 states participated in an online survey to gauge the level of compliance with HCC surveillance guidelines. According to the survey, knowledge gaps and barriers to HCC screening in ...
Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a leading cause of cancer-related deaths worldwide. While environmental and genetic factors contribute to HCC, increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results